Experimental Model of Pulmonary Inflammation Induced by SARSCoV‑2 Spike Protein and Endotoxin April 7, 2022 READ ARTICLE
CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production September 14, 2021 READ ARTICLE
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics July 20, 2021 READ ARTICLE